Lv31
360 积分 2025-05-28 加入
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
25天前
已完结
Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis
9个月前
已完结
皖公网安备34019202002308
